MiR-93-5p inhibits ovarian cancer through SLC7A11-mediated-ferroptosis.

ABSTRACT:

Aim

Ovarian cancer (OC) is the most lethal gynecological malignancy, which seriously affects the prognosis and life quality of female patients. Therefore, new therapeutic targets and treatments are urgently needed.

Methods

Expression levels of miR-93-5p and SLC7A11 and ferroptosis status in paracancerous and tumor tissues were examined and compared. The effect of the miR-93-5p-SLC7A11 regulatory loop on the malignant phenotype as well as the ferroptosis phenotype of SKOV3 cells was assessed. Furthermore, the interaction between miR-93-5p and SLC7A11 was confirmed via rescue experiment.

Results

In this study, we found that miR-93-5p was lowly expressed in cancer tissues, and suggested that overexpression of miR-93-5p could target SLC7A11 to reduce its expression and pr

SUBMITTER: Li C 

PROVIDER: S-EPMC11334884 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature